Your browser doesn't support javascript.
loading
Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study.
Tang, Lin; Zhang, Yanyang; Wang, Fuzhen; Wu, Dan; Qian, Zhao-Hui; Zhang, Rui; Wang, Ai-Bin; Huang, Chang; Wang, Haifeng; Ye, Ying; Lu, Mingxia; Wang, Changshuang; Ma, Ya-Ting; Pan, Jingjing; Li, Ya-Fei; Lv, Xiao-Ya; An, Zhijie; Rodewald, Lance; Wang, Xuan-Yi; Shao, Yi-Ming; Wu, Zhi-Yin; Yin, Zundong.
Afiliación
  • Tang L; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang Y; Department of Henan Immunization Program, Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • Wang F; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wu D; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Qian ZH; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhang R; National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Wang AB; Beijing Ditan Hospital Capital Medical University, Beijing, China.
  • Huang C; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang H; China Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Ye Y; Department of Communicable Disease Control and Prevention, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • Lu M; Department of Communicable Disease Control and Prevention, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • Wang C; Department of Henan Immunization Program, Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • Ma YT; Department of Henan Immunization Program, Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • Pan J; Department of Henan Immunization Program, Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • Li YF; Department of Communicable Disease Control and Prevention, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • Lv XY; Department of Communicable Disease Control and Prevention, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan, China.
  • An Z; Development Center for Medicine and Science & Technology, National Health Commission, Beijing, China.
  • Rodewald L; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang XY; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Shao YM; Shanghai Institute of Infectious Disease and Biosecurity, Key Laboratory of Medical Molecular Virology of Minstry of Eduation & Ministry of Health, and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China yinzd@chinacdc.cn yshao@chinaaids.cn zhiyinwu
  • Wu ZY; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China yinzd@chinacdc.cn yshao@chinaaids.cn zhiyinwu@126.com xywang@shmu.edu.cn.
  • Yin Z; Development Center for Medicine and Science & Technology, National Health Commission, Beijing, China yinzd@chinacdc.cn yshao@chinaaids.cn zhiyinwu@126.com xywang@shmu.edu.cn.
BMJ Open ; 12(11): e063919, 2022 11 11.
Article en En | MEDLINE | ID: mdl-36368753
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article